|Bid||47.23 x 2200|
|Ask||47.24 x 2200|
|Day's Range||47.18 - 47.67|
|52 Week Range||32.22 - 47.67|
|Beta (3Y Monthly)||0.13|
|PE Ratio (TTM)||29.60|
|Forward Dividend & Yield||0.72 (1.54%)|
|1y Target Est||52.00|
Examining how Smith & Nephew plc (LON:SN.) is performing as a company requires looking at more than just a years...
Nancy Zambell, editor of Wall Street's Best Investments, chose Smith & Nephew plc (SNN) as her top conservative investment idea for 2019. The stock rose 16.5% in the first half of the year. Here's her latest update on the healthcare firm.
Looking at Smith & Nephew plc's (LON:SN.) earnings update in December 2018, it seems that analyst forecasts are fairly...
LONDON , July 11, 2019 /PRNewswire/ -- Smith & Nephew (NYSE: SNN; LSE: SN), the global medical technology business, today announces the results of the first ever prospective clinical trial to evaluate ...
With Smith & Nephew's (SNN) buyout of Atracsys, the latter's fusionTrack 500 optical tracking camera will be a core enabling technology for the company's next-generation robotics platform.
This article is for investors who would like to improve their understanding of price to earnings ratios (P/E ratios...
With the first-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the first quarter. One of these stocks was Smith & Nephew plc (NYSE:SNN). Smith & Nephew plc (NYSE:SNN) […]
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. On...
Logistics firm DHL Supply Chain will expand its medical device and pharmaceutical logistics business in Memphis, bringing about 50 more jobs and $8 million in capital investment.
The transaction by Smith & Nephew (SNN), besides the business purchase, comprises certain intangible assets and the orthopaedic Brainlab salesforce.
Titan Medical (TMDI) is putting in a good deal of effort to strengthen its position in the multi-billion dollar computer-assisted robotic surgical technologies market.
When a Californian company founded by a U.S. veteran wounded in Afghanistan sought to register a new medical device this year, it turned to Europe before the United States. "Now it has flipped," said Bill Colone, CEO of San Clemente-based Spinal Singularity, which hopes to launch a 'smart' catheter for men with spinal injuries or disease early next year after squeezing in its application under the old European rules. Colone is part of a chorus of industry voices warning that a switch to stricter European rules governing medical devices, due to come into force a year from now, will slow or even halt the release of products in Europe that could transform patients' lives.
LONDON , June 5, 2019 /PRNewswire/ -- Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, has announced the launch of its CONQUEST FN™ system, a new implant solution to treat femoral ...
LONDON , May 22, 2019 /PRNewswire/ -- Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, today presented new data at the International Society for Pharmacoeconomics and Outcomes ...
LONDON , May 13, 2019 /PRNewswire/ -- Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, today announces the U.S. launch of the WEREWOLF™ FLOW 90 Wand with FLOW~IQ™ Technology. ...
Smith & Nephew , the global medical technology business, welcomes the launch of new medical technologies guidance from the UK National Institute for Health and Care Excellence .